APIC Text Online: New coverage on C. difficile

A subscription to APIC Text Online provides instant access to 123 chapters of regularly updated guidelines, regulations, clinical standards, research, and best practices. In the newly updated Clostridium difficile chapter, Jason E. Bowling, MD discusses the latest IDSA and SHEA treatment guidelines, NAATs and their impact on reported CDI rates, bezlotoxumab as an alternative therapy for recurrent infection, and the potential role of UV-C devices as a disinfection modality. Learn more and subscribe.